Terrie Westfahl Meier
Psychiatric/Mental Health · Wellington, KSNPI 1790861227
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,728 and has fallen 65.9% since, to $589 in 2025.
Across 253 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$591
- Vanda Pharmaceuticals Inc.$586
- Otsuka America Pharmaceutical, Inc.$474
- Alkermes, Inc.$442
- Neurocrine Biosciences, Inc.$344
- Takeda Pharmaceuticals U.S.A., Inc.$299
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,826100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 28 | $591 |
| Vanda Pharmaceuticals Inc. | 22 | $586 |
| Otsuka America Pharmaceutical, Inc. | 25 | $474 |
| Alkermes, Inc. | 23 | $442 |
| Neurocrine Biosciences, Inc. | 26 | $344 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $299 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $295 |
| AbbVie | 13 | $259 |
| Teva Pharmaceuticals USA, Inc. | 12 | $249 |
| Merck | 14 | $220 |
| Axsome Therapeutics, Inc. | 8 | $170 |
| Neos Therapeutics, LP | 10 | $155 |
| Corium, LLC | 6 | $126 |
| Bausch Health US, LLC | 7 | $116 |
| Idorsia Pharmaceuticals US Inc | 7 | $114 |
| Sunovion Pharmaceuticals Inc. | 7 | $100 |
| Johnson & Johnson | 5 | $83 |
| Ironshore Pharmaceuticals Inc. | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Avanir Pharmaceuticals, Inc. | 2 | $37 |
| Almatica Pharma LLC | 1 | $21 |
| Eisai Inc. | 1 | $17 |
How this compares
$4,826 in reported general payments places this provider in the 85th percentile of 404 psychiatric/mental health providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $684 |
| Zolpidem Tartrate ErZolpidem Tartrate | 19 | $499 |
| Lurasidone Hcl | 11 | $357 |
| Duloxetine Hcl | 23 | $303 |
| Alprazolam | 34 | $263 |
| Bupropion XlBupropion Hcl | 13 | $174 |
| Lamotrigine | 16 | $144 |
| Amitriptyline Hcl | 12 | $142 |
| Trazodone Hcl | 12 | $3 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Wellington
- Eric ThomasonPittsburg$333K
- Belinda BagbyHutchinson$39K
- Hayley KnappWichita$31K
- Jennifer KubinBaldwin City$26K
- Uyen DinhPittsburg$20K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
- Deborah MurphyWichita$13K
- Marijen AgaShawnee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.